News
Medical Device Network on MSN2d
Weill Cornell receives grant to test new imaging approach for prostate cancerWeill Cornell Medicine in the US has secured a grant of approximately $4m from the National Cancer Institute for a clinical ...
Dr Wouter Vogel, radiation oncologist at the Netherlands Cancer Institute, explained that the reason the glands have gone ...
A VISION-like, Single-Center Analysis Unspecific 18F-PSMA-1007 Bone Uptake Evaluated Through PSMA-11 PET, Bone Scanning, and MRI Triple Validation in Patients with Biochemical Recurrence of Prostate ...
Commissions do not affect our editors' opinions or evaluations. Pet insurance companies often cover dental-related injuries, but there’s wide variation on whether pet insurance policies cover ...
PSMA-PET imaging represents a significant advancement in prostate cancer management, largely replacing conventional imaging methods (bone scan, CT [4] scan) as the standard of care after initial ...
Illuccix, after radiolabelling with gallium-68, is indicated in France for the detection of prostate-specific membrane antigen (PSMA)-positive lesions with PET in adults with prostate cancer (PCa) in ...
Illuccix, after radiolabelling with gallium-68, is indicated in France for the detection of prostate-specific membrane antigen (PSMA)-positive lesions with PET in adults with prostate cancer (PCa) in ...
Illuccix, after radiolabelling with gallium-68, is indicated in France for the detection of prostate-specific membrane antigen (PSMA)-positive lesions with PET in adults with prostate cancer (PCa ...
MELBOURNE, Australia, April 29, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET 1 imaging agent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback